\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ currently\\ followed\\ by\\ rheumatology\\.\ \(0\)\
\-\ feet\\:\\ \\ the\\ fifth\\ pip\\/dip\\ demonstrate\\ erosion\\ with\\ pencil\\ in\\ cup\\ deformity\\.\\ \\ marginal\\ erosions\\ of\\ the\\ lateral\\ fifth\\ metatarsal\\ is\\ present\\ with\\ sclerotic\\ margin\\.\ \(0\)\
\-\ hands\\:\\ \\ loss\\ of\\ joint\\ space\\ of\\ the\\ dip\\ joints\\ of\\ the\\ left\\ second\\,\\ third\\,\\ fourth\\ and\\ fifth\\ digits\\ and\\ right\\ dip\\ joints\\ with\\ prolific\\ bone\\ formation\\.\\ \\ erosions\\ of\\ the\\ mcp\\ joints\\ are\\ present\\.\\ \\ ankylosis\\ of\\ the\\ left\\ first\\ dip\\ and\\ partial\\ ankylosis\\ of\\ the\\ right\\ first\\ dip\\ joint\\.\ \(0\)\
\-\ psoriatic\\ arthritis\ \(11\)\
\-\ erosive\\ osteoarthritis\ \(8\)\
\-\ psoriatic\\ arthritis\ \(11\)\
\-\ history\\ of\\ psoriasis\\.\ \(1\)\
\-\ psoriasis\\ is\\ a\\ chronic\\,\\ inflammatory\\,\\ proliferative\\ disease\\ of\\ the\\ skin\\.\\ \\ psoriatic\\ arthritis\\ occurs\\ in\\ 5\\-8\\ percent\\ of\\ patients\\ with\\ psoriasis\\.\\ \\ the\\ mean\\ age\\ of\\ diagnosis\\ is\\ 40\\ years\\ and\\ ranges\\ from\\ 20\\ to\\ 39\\ years\\ in\\ men\\ and\\ 40\\ to\\ 59\\ years\\ in\\ women\\.\\ \\ bone\\ erosion\\ and\\ proliferation\\ can\\ strongly\\ suggest\\ the\\ diagnosis\\.\\ \\ erosions\\ begin\\ in\\ the\\ joint\\ margins\\ and\\ extend\\ along\\ the\\ articular\\ surface\\ or\\ progress\\ away\\ from\\ the\\ joint\\.\\ \\ severe\\ erosions\\ may\\ widen\\ the\\ joint\\ space\\ and\\ lead\\ to\\ a\\ pencil\\ in\\ cup\\ or\\ cup\\ and\\ saucer\\ appearance\\.\\ \\ asymmetric\\ dip\\ or\\ ip\\ joint\\ involvement\\ and\\ involvement\\ of\\ a\\ few\\ rays\\ are\\ characteristic\\.\\ \\ \ \(0\)\
\-\ bennett\\,\\ dl\\,\\ ohashi\\,\\ k\\,\\ and\\ el\\-khoury\\,\\ gy\\ \\"spondyloarthropathies\\:\\ ankylosing\\ spondylitis\\ and\\ psoriatic\\ \\ arthritis\\"\\.\\ \\ radiologic\\ clinics\\ of\\ north\\ america\\.\\ \\ 42\\ \\(2004\\)\\ 121\\-134\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dip\\:\\ 0\\.4052100723865098\ \(0\)\
\-\ psoriatic\\:\\ 0\\.2493502765780496\ \(0\)\
\-\ cup\\:\\ 0\\.2449199797486828\ \(0\)\
\-\ erosions\\:\\ 0\\.2328485064446778\ \(0\)\
\-\ joint\\:\\ 0\\.2294706210603166\ \(0\)\
\-\ psoriasis\\:\\ 0\\.21498136379328375\ \(0\)\
\-\ arthritis\\:\\ 0\\.18882079630821128\ \(0\)\
\-\ fifth\\:\\ 0\\.17314711961519386\ \(0\)\
\-\ pencil\\:\\ 0\\.17153087156580774\ \(0\)\
\-\ the\\:\\ 0\\.16213399428987563\ \(0\)\
\-\ joints\\:\\ 0\\.14965845586478915\ \(0\)\
\-\ of\\:\\ 0\\.1476551601362495\ \(0\)\
\-\ and\\:\\ 0\\.14391802776207605\ \(0\)\
\-\ ankylosis\\:\\ 0\\.13778727932862442\ \(0\)\
\-\ erosion\\:\\ 0\\.10772611528579659\ \(0\)\
\-\ years\\:\\ 0\\.10673246082832481\ \(0\)\
\-\ prolific\\:\\ 0\\.09281792637547519\ \(0\)\
\-\ ohashi\\:\\ 0\\.09281792637547519\ \(0\)\
\-\ widen\\:\\ 0\\.08869248384213226\ \(0\)\
\-\ in\\:\\ 0\\.08663018580690075\ \(0\)\
\-\ saucer\\:\\ 0\\.08576543578290387\ \(0\)\
\-\ 40\\:\\ 0\\.08537024903396806\ \(0\)\
\-\ involvement\\:\\ 0\\.08401551231429384\ \(0\)\
\-\ spondyloarthropathies\\:\\ 0\\.08163999324956094\ \(0\)\
\-\ gy\\:\\ 0\\.07871294519033256\ \(0\)\
\-\ first\\:\\ 0\\.07833460180634694\ \(0\)\
\-\ space\\:\\ 0\\.0772673587025675\ \(0\)\
\-\ bennett\\:\\ 0\\.07644255032965504\ \(0\)\
\-\ ip\\:\\ 0\\.07547280802196321\ \(0\)\
\-\ rheumatology\\:\\ 0\\.07301908219765517\ \(0\)\
\-\ proliferative\\:\\ 0\\.07301908219765517\ \(0\)\
\-\ clinics\\:\\ 0\\.07301908219765517\ \(0\)\
\-\ america\\:\\ 0\\.06842031742939189\ \(0\)\
\-\ ranges\\:\\ 0\\.0671196648764062\ \(0\)\
\-\ begin\\:\\ 0\\.0671196648764062\ \(0\)\
\-\ north\\:\\ 0\\.0671196648764062\ \(0\)\
\-\ marginal\\:\\ 0\\.06672061007490789\ \(0\)\
\-\ mcp\\:\\ 0\\.06633661759030372\ \(0\)\
\-\ mean\\:\\ 0\\.06399113314007235\ \(0\)\
\-\ digits\\:\\ 0\\.06340956953107536\ \(0\)\
\-\ bone\\:\\ 0\\.0633364094942954\ \(0\)\
\-\ ankylosing\\:\\ 0\\.06259516754156494\ \(0\)\
\-\ proliferation\\:\\ 0\\.0623375691445124\ \(0\)\
\-\ spondylitis\\:\\ 0\\.061841149071740896\ \(0\)\
\-\ erosive\\:\\ 0\\.061601735832708664\ \(0\)\
\-\ rays\\:\\ 0\\.06069673134598846\ \(0\)\
\-\ or\\:\\ 0\\.060572810984778035\ \(0\)\
\-\ away\\:\\ 0\\.06027272861240644\ \(0\)\
\-\ diagnosis\\:\\ 0\\.060174615554219366\ \(0\)\
\-\ present\\:\\ 0\\.059563988873880126\ \(0\)\
\-\ men\\:\\ 0\\.05909743197614305\ \(0\)\
\-\ progress\\:\\ 0\\.05909743197614305\ \(0\)\
\-\ strongly\\:\\ 0\\.058383132202967085\ \(0\)\
\-\ metatarsal\\:\\ 0\\.05771570653839795\ \(0\)\
\-\ percent\\:\\ 0\\.05739772462165904\ \(0\)\
\-\ hands\\:\\ 0\\.05503384126369456\ \(0\)\
\-\ 59\\:\\ 0\\.05503384126369456\ \(0\)\
\-\ 2004\\:\\ 0\\.054668247686823504\ \(0\)\
\-\ feet\\:\\ 0\\.054549245240137344\ \(0\)\
\-\ radiologic\\:\\ 0\\.05408668407782651\ \(0\)\
\-\ extend\\:\\ 0\\.053536572095740594\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.05301468369126355\ \(0\)\
\-\ articular\\:\\ 0\\.05301468369126355\ \(0\)\
\-\ women\\:\\ 0\\.05223163640516109\ \(0\)\
\-\ asymmetric\\:\\ 0\\.05223163640516109\ \(0\)\
\-\ fourth\\:\\ 0\\.052044941383571734\ \(0\)\
\-\ dl\\:\\ 0\\.0519528629885951\ \(0\)\
\-\ lead\\:\\ 0\\.051681524423075186\ \(0\)\
\-\ 42\\:\\ 0\\.051592662782220765\ \(0\)\
\-\ margin\\:\\ 0\\.05090839873035161\ \(0\)\
\-\ margins\\:\\ 0\\.0495187982200742\ \(0\)\
\-\ few\\:\\ 0\\.0492341756551989\ \(0\)\
\-\ sclerotic\\:\\ 0\\.048687757480815136\ \(0\)\
\-\ surface\\:\\ 0\\.04842517276011278\ \(0\)\
\-\ 39\\:\\ 0\\.048232587959369765\ \(0\)\
\-\ is\\:\\ 0\\.047683601301117665\ \(0\)\
\-\ deformity\\:\\ 0\\.04743777133337335\ \(0\)\
\-\ suggest\\:\\ 0\\.0471478772735851\ \(0\)\
\-\ characteristic\\:\\ 0\\.04692176589708785\ \(0\)\
\-\ from\\:\\ 0\\.04610172244890465\ \(0\)\
\-\ formation\\:\\ 0\\.046013193672663925\ \(0\)\
\-\ occurs\\:\\ 0\\.04576070942158677\ \(0\)\
\-\ with\\:\\ 0\\.045459502787460505\ \(0\)\
\-\ partial\\:\\ 0\\.04471867840338928\ \(0\)\
\-\ currently\\:\\ 0\\.044584505999243386\ \(0\)\
\-\ third\\:\\ 0\\.044192288962252316\ \(0\)\
\-\ are\\:\\ 0\\.044046763253483286\ \(0\)\
\-\ to\\:\\ 0\\.04352934424567522\ \(0\)\
\-\ second\\:\\ 0\\.04345049222747598\ \(0\)\
\-\ skin\\:\\ 0\\.04317601642161963\ \(0\)\
\-\ left\\:\\ 0\\.03959713431568288\ \(0\)\
\-\ inflammatory\\:\\ 0\\.03924586958088014\ \(0\)\
\-\ followed\\:\\ 0\\.03919342310803265\ \(0\)\
\-\ along\\:\\ 0\\.03888429776582163\ \(0\)\
\-\ right\\:\\ 0\\.03848504553276182\ \(0\)\
\-\ 20\\:\\ 0\\.0374435401256576\ \(0\)\
\-\ severe\\:\\ 0\\.03674156572431452\ \(0\)\
\-\ age\\:\\ 0\\.036437823968337925\ \(0\)\
\-\ loss\\:\\ 0\\.035359840286569424\ \(0\)\
\-\ appearance\\:\\ 0\\.034989814301349544\ \(0\)\
\-\ chronic\\:\\ 0\\.034450636864328754\ \(0\)\
\-\ patients\\:\\ 0\\.032650438883546566\ \(0\)\
\-\ can\\:\\ 0\\.030457333762329564\ \(0\)\
\-\ demonstrate\\:\\ 0\\.030173169832681812\ \(0\)\
\-\ may\\:\\ 0\\.02920734761488777\ \(0\)\
\-\ lateral\\:\\ 0\\.02880376976676961\ \(0\)\
\-\ by\\:\\ 0\\.024646972530018716\ \(0\)\
\-\ disease\\:\\ 0\\.02436295452126772\ \(0\)\
\-\ history\\:\\ 0\\.022174480158975374\ \(0\)\
